Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Pharmacology and Toxicology Studies
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Role of SMC1 Phosphorylation in Radiation Responses
Calcium-Induced Calcium Release & Urinary Obstruction
Biophysical Channel Models of Associative Learning
Effect of Ambient Pressure on Gas Phase Diffusion Processes
Lung Fibroblasts Assessed by Monoclonal Antibodies
Recently added grants:
Understanding the full spectrum of epigenetic vulnerability in cancer through the delineation of DNA methylation function in gene 3' end
Augmenting Pancreatic Cancer Immunotherapy via TGF? Pathway Inhibition
Investigating the Molecular Basis of Olaparib Resistance in BRCA2-Deficient Prostate Cancer
Enhanced Immunotherapy by Targeting the Pros1:Macrophage Mer Axis
Improved Radiation Therapy of Hypoxic Tumor Regions by Integrated PET, EPR, and MR Imaging - Resubmission 01
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN43306-5-0-1
Application #
7575413
Study Section
Project Start
2004-06-30
Project End
2009-06-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Preclinical Pharmacology and Toxicology Studies
/ University of Illinois at Chicago
$1,278,125
NIH 2007
N01 CA
Preclinical Pharmacology and Toxicology Studies
Lyubimov, Alex /
$1,310,660
NIH 2007
N01 CA
Preclinical Pharmacology and Toxicology Studies
/
Comments
Be the first to comment on this grant